GenEndeavor

About:

GenEndeavor develops technology platforms to enable early detection of genetic and infectious diseases.

Website: https://genendeavor.com/

Twitter/X: genendeavor_llc

Top Investors: National Science Foundation

Description:

GenEndeavor is a biotechnology firm that creates platforms for the next generation of molecular technology to enable quick and accurate identification of infectious and genetic illnesses in real time at the point of presentation. Its objective is to increase access to extremely early genetic and infectious illness screening. They aim to identify diseases while they are still curable by lowering the detection limit of uncommon mutations and infections. Its assay technology platforms will make point-of-care testing sensitive, quick, and economical.

Total Funding Amount:

$621000

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Hayward, California, United States

Founded Date:

2010-01-01

Founders:

Number of Employees:

1-10

Last Funding Date:

2012-08-07

IPO Status:

Private

Industries:

© 2025 bioDAO.ai